NEW YORK STOCK EXCHANGE, INC. · DGX
+1.37% · +$2.66 · Vol 488.8K
Quest Diagnostics Inc

Quest Diagnostics Inc

Health Care
$196.24

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is DGX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Quest Diagnostics Inc
SERVICES-MEDICAL LABORATORIES
Listed since
1996
Employees
57K
Country
US

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$195.78
Day high
$197.79
Day low
$194.15
Previous close
$193.58
52W high
$204.24
-3.92% from high
52W low
$193.58
25% of range
Market cap
$21.6B
P/E
22.27×
EPS
$8.81
Shares out
110.7M
Volume
488.8K
VWAP
$196.85
Price history computed in-house
1W
-1.38%
SMA 50 $199.40 · below
SMA 200 $199.40 · below
52W position 25%
Veridion warehouse edge

Warehouse intelligence for DGX.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

DGX insider activity

Quest Diagnostics Inc

Score
Coverage building
Pressure
Net selling
Filings
135
Buys / sells
63 / 72
Net value
-$1.7M
Insiders
12
Named filers
KK
KUPPUSAMY KARTHIK
Insider
Leadership
DE
Davis J. E.
Insider
Leadership
SS
SAMAD SAM
Insider
Leadership
Cluster

7 insiders bought in the last 90 days

Net pressure

Net selling: -$1.7M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-082026-06-04KUPPUSAMY KARTHIKInsiderbuy$121.814,827Not reported$588KSEC Form 4
2026-06-082026-06-04KUPPUSAMY KARTHIKInsiderbuy$127.723,320Not reported$424KSEC Form 4
2026-06-082026-06-04KUPPUSAMY KARTHIKInsidersell$200.008,14713,510$1.6MSEC Form 4
2026-06-082026-06-04KUPPUSAMY KARTHIKInsiderbuy$121.814,82721,657$588KSEC Form 4
2026-06-082026-06-04KUPPUSAMY KARTHIKInsiderbuy$127.723,32016,830$424KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 130 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

DGX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for DGX in this window.
Lobbying spend

DGX lobbying filings, year to date.

Registered lobbying filings matched to Quest Diagnostics Inc.

$2.0M
Refresh interval: 12hSource: LDA disclosure filings
Health Issues Medicare/Medicaid Budget/AppropriationsBudget/Appropriations Health Issues Medicare/MedicaidHealth Issues Budget/Appropriations Medicare/Medicaid
Filing
$690.0K
QUEST DIAGNOSTICS INCORPORATED

QUEST DIAGNOSTICS INCORPORATED

Apr 20, 2026
Filing
$350.0K
QUEST DIAGNOSTICS INCORPORATED

QUEST DIAGNOSTICS INCORPORATED

Jan 20, 2026
Filing
$330.0K
QUEST DIAGNOSTICS INCORPORATED

QUEST DIAGNOSTICS INCORPORATED

Jan 20, 2026
Latest news · DGX
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for DGX.
Options
Sovereign unlock shows live options positioning for DGX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.